Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Constructing post-surgical discharge instructions through a Delphi consensus methodology.

Scott AR, Sanderson CJ, Rush AJ 3rd, Alore EA, Naik AD, Berger DH, Suliburk JW.

Patient Educ Couns. 2018 May;101(5):917-925. doi: 10.1016/j.pec.2017.12.004. Epub 2017 Dec 12.

PMID:
29254751
2.

A Cadaver Investigation of Screw Purchase With 2 Retrograde Techniques for Capitolunate Arthrodesis.

Linnell JD, Bernstein DT, Sanderson CJ, Netscher DT, Mitchell SA.

J Hand Surg Am. 2016 Mar;41(3):362-6. doi: 10.1016/j.jhsa.2015.11.020. Epub 2016 Jan 7.

PMID:
26774547
3.

Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed.

Croci DO, Cumashi A, Ushakova NA, Preobrazhenskaya ME, Piccoli A, Totani L, Ustyuzhanina NE, Bilan MI, Usov AI, Grachev AA, Morozevich GE, Berman AE, Sanderson CJ, Kelly M, Di Gregorio P, Rossi C, Tinari N, Iacobelli S, Rabinovich GA, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO), Italy.

PLoS One. 2011 Feb 28;6(2):e17283. doi: 10.1371/journal.pone.0017283.

4.

Further studies on the composition and structure of a fucoidan preparation from the brown alga Saccharina latissima.

Bilan MI, Grachev AA, Shashkov AS, Kelly M, Sanderson CJ, Nifantiev NE, Usov AI.

Carbohydr Res. 2010 Sep 23;345(14):2038-47. doi: 10.1016/j.carres.2010.07.009. Epub 2010 Jul 15.

PMID:
20701899
5.

The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Tam V, O'Brien-Simpson NM, Chen YY, Sanderson CJ, Kinnear B, Reynolds EC.

Infect Immun. 2009 Apr;77(4):1451-8. doi: 10.1128/IAI.01377-08. Epub 2009 Jan 21.

6.

A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds.

Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia, Italy.

Glycobiology. 2007 May;17(5):541-52. Epub 2007 Feb 12.

PMID:
17296677
7.

Transcription factor GATA-3 is involved in repression of promoter activity of the human interleukin-4 gene.

Schwenger GT, Mordvinov VA, Sanderson CJ.

Biochemistry (Mosc). 2005 Sep;70(9):1065-9.

8.

Dexamethasone suppresses human interleukin-5 gene promoter.

Mordvinov VA, Kok CC, Arthaningtyas E, Schwenger GT, Cristow A, Sanderson CJ.

Bull Exp Biol Med. 2005 Jul;140(1):80-2.

PMID:
16254627
9.

The conserved lymphokine element 0 is a powerful activator and target for corticosteroid inhibition in human interleukin-5 transcription.

Arthaningtyas E, Kok CC, Mordvinov VA, Sanderson CJ.

Growth Factors. 2005 Sep;23(3):211-21.

PMID:
16243713
10.

Distal regulatory elements play an important role in regulation of the human IL-5 gene.

Urwin DL, Schwenger GT, Groth DM, Sanderson CJ.

Eur J Immunol. 2004 Dec;34(12):3633-43.

11.

Specific activation of human interleukin-5 depends on de novo synthesis of an AP-1 complex.

Schwenger GT, Kok CC, Arthaningtyas E, Thomas MA, Sanderson CJ, Mordvinov VA.

J Biol Chem. 2002 Dec 6;277(49):47022-7. Epub 2002 Sep 26.

12.

Regulation of IL-5 expression.

Mordvinov VA, Sanderson CJ.

Arch Immunol Ther Exp (Warsz). 2001;49(5):345-51. Review.

PMID:
11798132
13.

GATA-3 has dual regulatory functions in human interleukin-5 transcription.

Schwenger GT, Fournier R, Kok CC, Mordvinov VA, Yeoman D, Sanderson CJ.

J Biol Chem. 2001 Dec 21;276(51):48502-9. Epub 2001 Sep 28.

14.

Binding of octamer factors to the murine IL-5 CLE0 in primary T-cells and a T-cell line.

Salerno MS, Schwenger GT, Sanderson CJ, Mordvinov VA.

Cytokine. 2001 Jul 7;15(1):4-9.

PMID:
11509003
15.

Interleukin-5: a drug target for allergic diseases.

Sanderson CJ, Urwin D.

Curr Opin Investig Drugs. 2000 Dec;1(4):435-41. Review.

PMID:
11249696
16.

Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction.

Czabotar PE, Holland J, Sanderson CJ.

Cytokine. 2000 Jul;12(7):867-73.

PMID:
10880230
17.

Binding of octamer factors to a novel 3'-positive regulatory element in the mouse interleukin-5 gene.

Salerno MS, Mordvinov VA, Sanderson CJ.

J Biol Chem. 2000 Feb 11;275(6):4525-31.

18.

Role of nuclear factor of activated T cells (NFAT) in the expression of interleukin-5 and other cytokines involved in the regulation of hemopoetic cells.

De Boer ML, Mordvinov VA, Thomas MA, Sanderson CJ.

Int J Biochem Cell Biol. 1999 Oct;31(10):1221-36. Review.

PMID:
10582349
19.

Identification of residues involved in binding of IL5 to betacom using betaIL3 and betacom chimeras.

Czabotar PE, Holland J, Sanderson CJ.

FEBS Lett. 1999 Oct 22;460(1):99-102.

20.

A human T-cell line with inducible production of interleukins 5 and 4. A model for studies of gene expression.

Mordvinov VA, Peroni SE, De Boer ML, Kees UR, Sanderson CJ.

J Immunol Methods. 1999 Aug 31;228(1-2):163-8.

PMID:
10556553
21.

Nuclear factor of activated T cells and YY1 combine to repress IL-5 expression in a human T-cell line.

Schwenger GT, Fournier R, Hall LM, Sanderson CJ, Mordvinov VA.

J Allergy Clin Immunol. 1999 Oct;104(4 Pt 1):820-7.

PMID:
10518827
22.
23.

Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.

Mordvinov VA, Schwenger GT, Fournier R, De Boer ML, Peroni SE, Singh AD, Karlen S, Holland JW, Sanderson CJ.

J Allergy Clin Immunol. 1999 Jun;103(6):1125-35.

PMID:
10359895
24.

Analysis of the 5' and 3'UTRs in the post-transcriptional regulation of the interleukin-5 gene.

Thomas MA, Karlen S, D'Ercole M, Sanderson CJ.

Biochim Biophys Acta. 1999 Jan 18;1444(1):61-8.

PMID:
9931437
25.

Expressed luciferase viability assay (ELVA) for the measurement of cell growth and viability.

Coombe DR, Nakhoul AM, Stevenson SM, Peroni SE, Sanderson CJ.

J Immunol Methods. 1998 Jun 1;215(1-2):145-50.

PMID:
9744756
26.

Identification of two novel palindromic regulatory elements in the murine interleukin-5 promoter.

Schwenger GT, Mordvinov VA, Karlen S, D'Ercole M, Sanderson CJ.

Mol Immunol. 1998 Feb;35(3):149-58.

PMID:
9694515
27.

New directions in understanding interleukin-5 gene expression.

Schwenger GT, Sanderson CJ.

Leuk Lymphoma. 1998 Feb;28(5-6):443-50. Review.

PMID:
9613973
28.

Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix.

Lipscombe RJ, Nakhoul AM, Sanderson CJ, Coombe DR.

J Leukoc Biol. 1998 Mar;63(3):342-50.

PMID:
9500522
29.

Biological and molecular characteristics of interleukin-5 and its receptor.

Karlen S, De Boer ML, Lipscombe RJ, Lutz W, Mordvinov VA, Sanderson CJ.

Int Rev Immunol. 1998;16(3-4):227-47. Review.

PMID:
9505190
30.

Eosinophilic interleukin 5 (IL-5) transgenic mice: eosinophil activity and impaired clearance of Schistosoma mansoni.

Dent LA, Munro GH, Piper KP, Sanderson CJ, Finlay DA, Dempster RK, Bignold LP, Harkin DG, Hagan P.

Parasite Immunol. 1997 Jul;19(7):291-300.

31.

Anti-interleukin 5 strategies as a potential treatment for asthma.

Singh AD, Sanderson CJ.

Thorax. 1997 May;52(5):483-5.

32.

Production of human and murine eosinophils in vitro and assay for eosinophil differentiation factors.

Strath M, Clutterbuck EJ, Sanderson CJ.

Methods Mol Biol. 1997;75:273-87. Review. No abstract available.

PMID:
9276277
33.

Diagnostic criteria for selenium toxicosis in aquatic birds: dietary exposure, tissue concentrations, and macroscopic effects.

Albers PH, Green DE, Sanderson CJ.

J Wildl Dis. 1996 Jul;32(3):468-85. Erratum in: J Wildl Dis 1996 Oct;32(4):725-6.

PMID:
8827673
34.
35.

How is expression of the interleukin-5 gene regulated?

Karlen S, Mordvinov VA, Sanderson CJ.

Immunol Cell Biol. 1996 Apr;74(2):218-23. Review.

PMID:
8724013
36.

Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor.

Cornelis S, Plaetinck G, Devos R, Van der Heyden J, Tavernier J, Sanderson CJ, Guisez Y, Fiers W.

EMBO J. 1995 Jul 17;14(14):3395-402.

37.

Human interleukin-5 induces staphylococcal A Cowan 1 strain-activated human B cells to secrete IgM.

Bertolini JN, Sanderson CJ, Benson EM.

Eur J Immunol. 1993 Feb;23(2):398-402.

PMID:
8436175
38.

Interactive effects of selenium, methionine, and dietary protein on survival, growth, and physiology in mallard ducklings.

Hoffman DJ, Sanderson CJ, LeCaptain LJ, Cromartie E, Pendleton GW.

Arch Environ Contam Toxicol. 1992 Aug;23(2):163-71.

PMID:
1514839
39.

Release of granule proteins from eosinophils cultured with IL-5.

Kita H, Weiler DA, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ.

J Immunol. 1992 Jul 15;149(2):629-35.

PMID:
1624806
40.

Interleukin-5, eosinophils, and disease.

Sanderson CJ.

Blood. 1992 Jun 15;79(12):3101-9. Review. No abstract available.

PMID:
1596561
41.

Comparison of Nissen total and Lind partial transabdominal fundoplication in the treatment of gastro-oesophageal reflux.

Walker SJ, Holt S, Sanderson CJ, Stoddard CJ.

Br J Surg. 1992 May;79(5):410-4.

PMID:
1596721
42.

Interleukin-5.

McKenzie AN, Sanderson CJ.

Chem Immunol. 1992;51:135-52. Review. No abstract available.

PMID:
1567540
43.

Interactive effects of arsenate, selenium, and dietary protein on survival, growth, and physiology in mallard ducklings.

Hoffman DJ, Sanderson CJ, LeCaptain LJ, Cromartie E, Pendleton GW.

Arch Environ Contam Toxicol. 1992 Jan;22(1):55-62.

PMID:
1554253
44.

Pharmacological implications of interleukin-5 in the control of eosinophilia.

Sanderson CJ.

Adv Pharmacol. 1992;23:163-77. Review. No abstract available.

PMID:
1540534
45.

Eosinophil differentiation of human umbilical cord mononuclear cells and prolonged survival of mature eosinophils by murine EL-4 thymoma cell conditioned medium.

Ten RM, Butterfield JH, Kita H, Weiler DA, Fischkoff S, Ishizaka T, Sanderson CJ, Gleich GJ.

Cytokine. 1991 Jul;3(4):350-9.

PMID:
1873484
46.

Analysis of interleukin 5 receptors on murine eosinophils: a comparison with receptors on B13 cells.

Barry SC, McKenzie AN, Strath M, Sanderson CJ.

Cytokine. 1991 Jul;3(4):339-44.

PMID:
1873482
47.

Structure-function analysis of interleukin-5 utilizing mouse/human chimeric molecules.

McKenzie AN, Barry SC, Strath M, Sanderson CJ.

EMBO J. 1991 May;10(5):1193-9.

48.

Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems.

Ingley E, Cutler RL, Fung MC, Sanderson CJ, Young IG.

Eur J Biochem. 1991 Mar 28;196(3):623-9.

49.

Interactive effects of boron, selenium, and dietary protein on survival, growth, and physiology in mallard ducklings.

Hoffman DJ, Sanderson CJ, LeCaptain LJ, Cromartie E, Pendleton GW.

Arch Environ Contam Toxicol. 1991 Feb;20(2):288-94.

PMID:
2015005
50.

Effect of steroids on immunoglobulin-induced eosinophil degranulation.

Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ.

J Allergy Clin Immunol. 1991 Jan;87(1 Pt 1):70-7.

PMID:
1991924

Supplemental Content

Loading ...
Support Center